Browse By: Country ι Category ι Tag

Arthritis Market Research Reports

Pipeline Review Of Rheumatoid Arthritis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. The cause of rheumatoid arthritis is not known. The joint inflammation of rheumatoid arthritis causes swelling, pain, stiffness and redness in the joints. It can lead to a significant loss of mobility due to pain and joint destruction. The disease is also systematic, i.e. it affect extra articular tissues throughout the body. The disease is three times more common in women as in men.Pharmacological treatment of rheumatoid arthritis can be divided into disease-modifying antirheumatic drugs (DMARDs), anti-inflammatory agents and analgesics. The highly innovative products are expected to increase the diversity of available products.  Rheumatoid Arthritis - Pipeline Review, provides an overview of the indication&rs
Published Date: Sep 2023
Published By: Transparency

Price: $5795
Psoriatic Arthritis Pharmacotherapy Market - Global Industry Analysis, Size, Share And Forecast, 2012 - 2018
Psoriatic Arthritis is a type of rheumatoid arthritis which mainly affects fingers and toes followed by psoriasis. Moreover, a condition in which person has both psoriasis and arthritis is identified to have suffered from psoriatic arthritis. Major symptom for psoriatic arthritis is associated with inflammation of the skin and joints. About 11% of patients who has psoriatic also develop inflammation of their joints in a time frame ranging from 6 months to 1 year or sometimes even more, depending upon the personality of the patient.  The global psoriatic arthritis pharmacotherapy market has experienced strong growth rate and is forecasted to experience continued growth in the future years due to increased use of biologics drugs mainly tumor necrosis factor inhibitor (TNF). There e
Published Date: Apr 2020
Published By: Transparency

Price: $5595
Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H1 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Idiopathic Juvenile Arthritis – Pipeline Review, H1 2017, provides an overview of the Systemic Idiopathic Juvenile Arthritis (Musculoskeletal Disorders) pipeline landscape. Systemic onset juvenile idiopathic arthritis (also known as Systemic juvenile idiopathic arthritis (sJIA)) is a disorder featuring inflammation, characterized by high spiking fevers, salmon-colored rash that comes and goes, and arthritis. Symptoms are extreme fatigue accompanied by high fevers that rise daily to 102 F (39 C) or even higher and rapidly return to normal levels or below. Fever spikes often occur at approximately the same time every day. A faint salmon colored skin rash characteristically comes and goe
Published Date: Mar 2017
Published By: Global Markets Direct

Price: $2000
Global Psoriatic Arthritis Drug Market Size, Status and Forecast 2022
This report studies the global Psoriatic Arthritis Drug market, analyzes and researches the Psoriatic Arthritis Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Abbvie Janssen Amgen Pfizer Eli-lilly Celgene ... Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Psoriatic Arthritis Drug can be split into TNF Inhibitors PDE4 Inhibitors Interleukin Blockers Other Market segment by Application, Psoriatic Arthritis Drug can be split into Mild Psoriatic Arthritis Moderate Psoriatic Arthritis Severe Psoriatic Arthritis
Published Date: Mar 2017
Published By: QYResearch

Price: $3300
Global Psoriatic Arthritis (PsA) Treatments Market Size, Status and Forecast 2022
This report studies the global Psoriatic Arthritis (PsA) Treatments market, analyzes and researches the Psoriatic Arthritis (PsA) Treatments development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Celgene Corporation Amgen Inc AbbVie F Hoffmann-La Roche AG Janssen Global Services Eli Lilly and Company UCBInc Bristol-Myers Squibb Company Novartis AG Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Psoriatic Arthritis (PsA) Treatments can be split into TNF Inhibitors PDE4 Inhibitors Interleukin Blockers Others Market segment by Applica
Published Date: Mar 2017
Published By: QYResearch

Price: $3300
Osteoarthritis - Pipeline Review, H1 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis – Pipeline Review, H1 2017, provides an overview of the Osteoarthritis (Immunology) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery, medications like non-steroidal anti-inflammatory drugs (NSAIDs) and exercise. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Osteoarthritis – Pipeline Review, H1 2017, provides comprehensive
Published Date: Mar 2017
Published By: Global Markets Direct

Price: $2000
Global Rheumatoid Arthritis Treatments Market Size, Status and Forecast 2022
This report studies the global Rheumatoid Arthritis Treatments market, analyzes and researches the Rheumatoid Arthritis Treatments development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like AbbVie Inc Johnson & Johnson Services Amgen Inc Pfizer Cadila Healthcare Ltd Novartis AG AstraZeneca F Hoffman-La Roche Ltd Bristol-Myers Squibb Company GlaxoSmithKline Abbott Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Rheumatoid Arthritis Treatments can be split into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Corticosteroids Disease Mod
Published Date: Mar 2017
Published By: QYResearch

Price: $3300
Global Osteoarthritis Pain Drugs Industry 2017, Trends and Forecast Report
The report firstly introduced the Osteoarthritis Pain Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Osteoarthritis Pain Drugs Market; 3.) the North American Osteoarthritis Pain Drugs Market; 4.) the European Osteoarthritis Pain Drugs Market; 5.) market entry and investment feasibility;
Published Date: Feb 2017
Published By: 9Dimen Research

Price: $2850
Global Arthritis Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Global Rheumatoid Arthritis Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Global Osteoarthritis Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Europe Drugs for Osteoarthritis Pain Market Report 2017
Sales, means the sales volume of Drugs for Osteoarthritis Pain Revenue, means the sales value of Drugs for Osteoarthritis Pain This report studies sales (consumption) of Drugs for Osteoarthritis Pain in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Abbott Laboratories Johnson & Johnson Novartis International Pfizer AbbVie Abiogen Pharma Afferent Pharmaceuticals Astellas Pharma BioDelivery Sciences International CrystalGenomics Cytori Therapeutics Daiichi Sankyo Eli Lilly Endo Pharmaceuticals Holdings Horizon Pharma ICeutica Iroko Pharmaceuticals Merc
Published Date: Jan 2017
Published By: QYResearch

Price: $3900
Global Drugs for Osteoarthritis Pain Market Professional Survey Report 2017
Production, means the output of Drugs for Osteoarthritis Pain Revenue, means the sales value of Drugs for Osteoarthritis Pain This report studies Drugs for Osteoarthritis Pain in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Abbott Laboratories Johnson & Johnson Novartis International Pfizer AbbVie Abiogen Pharma Afferent Pharmaceuticals Astellas Pharma BioDelivery Sciences International CrystalGenomics Cytori Therapeutics Daiichi Sankyo E
Published Date: Jan 2017
Published By: QYResearch

Price: $3500
United States Drugs for Osteoarthritis Pain Market Report 2017
Sales, means the sales volume of Drugs for Osteoarthritis Pain Revenue, means the sales value of Drugs for Osteoarthritis Pain This report studies sales (consumption) of Drugs for Osteoarthritis Pain in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Abbott Laboratories Johnson & Johnson Novartis International Pfizer AbbVie Abiogen Pharma Afferent Pharmaceuticals Astellas Pharma BioDelivery Sciences International CrystalGenomics Cytori Therapeutics Daiichi Sankyo Eli Lilly Endo Pharmaceuticals Holdings Horizon Pharma ICeutica Iroko Pharmaceuticals Merck Nuvo Research Regeneron Pharmaceuticals Sanofi SantoSolve Techfields Pharm
Published Date: Jan 2017
Published By: QYResearch

Price: $3800
Global Drugs for Osteoarthritis Pain Sales Market Report 2017
Sales, means the sales volume of Drugs for Osteoarthritis Pain Revenue, means the sales value of Drugs for Osteoarthritis Pain This report studies sales (consumption) of Drugs for Osteoarthritis Pain in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Abbott Laboratories Johnson & Johnson Novartis International Pfizer AbbVie Abiogen Pharma Afferent Pharmaceuticals Astellas Pharma BioDelivery Sciences International CrystalGenomics Cytori Therapeutics Daiichi Sankyo Eli Lilly Endo Pharmaceuticals Holdings Horizon Pharma ICeutica Iroko Pharmaceuticals Merck Nuv
Published Date: Jan 2017
Published By: QYResearch

Price: $4000
China Drugs for Osteoarthritis Pain Market Research Report 2017
Sales, means the sales volume of Drugs for Osteoarthritis Pain Revenue, means the sales value of Drugs for Osteoarthritis Pain This report studies Drugs for Osteoarthritis Pain in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Abbott Laboratories Johnson & Johnson Novartis International Pfizer AbbVie Abiogen Pharma Afferent Pharmaceuticals Astellas Pharma BioDelivery Sciences International CrystalGenomics Cytori Therapeutics Daiichi Sankyo Eli Lilly Endo Pharmaceuticals Holdings Horizon Pharma ICeutica Iroko Pharmaceuticals Merck Nuvo Research Regeneron Pharmaceuticals Sanofi SantoSolve Techfields
Published Date: Jan 2017
Published By: QYResearch

Price: $3200
United States Osteoarthritis Pain Drugs Market Report 2017
Sales, means the sales volume of Osteoarthritis Pain Drugs Revenue, means the sales value of Osteoarthritis Pain Drugs This report studies sales (consumption) of Osteoarthritis Pain Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Abbott Laboratories Johnson & Johnson Novartis Pfizer AbbVie Abiogen Pharma Afferent Pharmaceuticals Astellas Pharma BioDelivery Sciences International CrystalGenomics Cytori Therapeutics Daiichi Sankyo Eli Lilly Endo Pharmaceuticals Holdings Horizon Pharma, iCeutica Iroko Pharmaceuticals Merck, Nuvo Research Regeneron Pharmaceuticals Sanofi, SantoSolve Techfields Pharma Winston Pharmaceuticals Y
Published Date: Jan 2017
Published By: QYResearch

Price: $3800
Global Osteoarthritis Pain Drugs Sales Market Report 2017
This report studies sales (consumption) of Osteoarthritis Pain Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions,
Published Date: Jan 2017
Published By: QYResearch

Price: $4000
Europe Osteoarthritis Pain Drugs Market Report 2017
This report studies sales (consumption) of Osteoarthritis Pain Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries,
Published Date: Jan 2017
Published By: QYResearch

Price: $3900
China Osteoarthritis Pain Drugs Market Research Report 2017
This report studies Osteoarthritis Pain Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer,
Published Date: Jan 2017
Published By: QYResearch

Price: $3200

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top